Fibrate Drugs Market
According to Intent Market Research, the Fibrate Drugs Market is expected to grow from USD 0.8 billion in 2023 at a CAGR of 5.7% to touch USD 1.1 billion by 2030. The Fibrate Drugs Market is dominated by key players such as, Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company, and AstraZeneca